TGFB1 and renal fibrosis: Consequently, the chronic administration of recombinant TGF-β1 or TGF-β2 causes renal fibrosis, proteinuria, and an elevated BP, presumably due to the loss of vascular elasticity, altered natriuresis, or both [81].